Clinical development of nintedanib for advanced non-small-cell lung cancer

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 5 X users

reddit: 1 Redditor

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity

Article in Frontiers in Oncology (August 2023)

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database

Article in Frontiers in Oncology (November 2022)

Solubility measurement and thermodynamic properties of Nintedanib Esylate Hemihydrate in pure solvents

Article in Journal of Molecular Liquids (April 2022)